Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral duloxetine for chemotherapy-induced peripheral neuropathy
IRCT20110514006480N16Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of duloxetine in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Shahrekord University of Medical Sciences. Started Aug 2018; status: completed.
02
Drugs
duloxetine
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20110514006480N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110514006480N16.